WCM Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-56,823
| Closed | -$6.74M | – | 222 |
|
|
2022
Q1 | $6.74M | Sell |
56,823
-7,948
| -12% | -$942K | 0.02% | 137 |
|
|
2021
Q4 | $8.93M | Buy |
64,771
+3,737
| +6% | +$515K | 0.02% | 135 |
|
|
2021
Q3 | $8.48M | Sell |
61,034
-21,179
| -26% | -$2.94M | 0.02% | 132 |
|
|
2021
Q2 | $7.98M | Buy |
82,213
+3,271
| +4% | +$318K | 0.02% | 132 |
|
|
2021
Q1 | $5.4M | Sell |
78,942
-1,716
| -2% | -$117K | 0.01% | 136 |
|
|
2020
Q4 | $6.91M | Buy |
80,658
+14,989
| +23% | +$1.28M | 0.02% | 131 |
|
|
2020
Q3 | $4.27M | Buy |
65,669
+3,919
| +6% | +$255K | 0.02% | 140 |
|
|
2020
Q2 | $4.52M | Buy |
61,750
+2,235
| +4% | +$163K | 0.02% | 131 |
|
|
2020
Q1 | $2.03M | Buy |
59,515
+17,226
| +41% | +$586K | 0.01% | 149 |
|
|
2019
Q4 | $2.3M | Buy |
42,289
+26,481
| +168% | +$1.44M | 0.01% | 143 |
|
|
2019
Q3 | $660K | Buy |
15,808
+6,990
| +79% | +$292K | ﹤0.01% | 134 |
|
|
2019
Q2 | $386K | Sell |
8,818
-132
| -1% | -$5.78K | ﹤0.01% | 145 |
|
|
2019
Q1 | $461K | Buy |
+8,950
| New | +$461K | ﹤0.01% | 136 |
|